Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nerea Báez Gutiérrez"'
Autor:
Nerea Báez Gutiérrez, Héctor Rodríguez Ramallo, Elva María Mendoza-Zambrano, Berenice Brown Arreola, Bernardo Santos Ramos, Laila Abdel-kader Martín, Remedios Otero Candelera
Publikováno v:
JMIR mHealth and uHealth, Vol 12, Pp e57289-e57289 (2024)
Abstract BackgroundPulmonary hypertension (PH) is a chronic and complex condition, requiring consistent management and education. The widespread use of smartphones has opened possibilities for mobile health apps to support both patients and health c
Externí odkaz:
https://doaj.org/article/f3857dbca05b4855b01d75bc7496c8e7
Autor:
Nerea Báez Gutiérrez, Héctor Rodríguez Ramallo, Marcos Fernández González, Laila Abdel-Kader Martín
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 10, p e43412 (2022)
Externí odkaz:
https://doaj.org/article/6692d9ce5bac48f4b6fc70dc6239711f
Autor:
Nerea Báez Gutiérrez, Héctor Rodríguez Ramallo, Marcos Fernández González, Laila Abdel-Kader Martín
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 9, p e35851 (2022)
BackgroundHematological malignancies (HMs) are a heterogeneous group of cancers representing a significant cause of morbidity and mortality. The chronification of HMs and the increasing use of smartphones may lead patients to seek their current unmet
Externí odkaz:
https://doaj.org/article/4786500112d7482fb9138fe15c1f75c2
Autor:
Héctor Rodríguez Ramallo, Nerea Báez Gutiérrez, Ana Sánchez Pedrosa, María del Carmen Saborido Cansino
Publikováno v:
Atención Primaria, Vol 53, Iss 6, Pp 102019- (2021)
Externí odkaz:
https://doaj.org/article/4a362cc418504529ab8e3147b7462a80
Autor:
Héctor, Rodríguez-Ramallo, Nerea, Báez-Gutiérrez, Laila, Abdel-Kader-Martín, Remedios, Otero-Candelera
Publikováno v:
Thrombosis Research.
Randomized controlled trials (RCTs) that conduct subgroup analyses have the potential to provide information on treatment decisions in specific groups of patients from heterogeneous populations. Although we understand several factors can modify the i
Autor:
Remedios Otero-Candelera, Laila Abdel-Kader Martin, Héctor Rodríguez Ramallo, Nerea Báez Gutiérrez
Pulmonary hypertension (PH) treatment decisions are driven by the results of randomized controlled trials (RCTs). Subgroup analyses are often performed to assess whether the intervention effect will change due to the patient’s characteristics, thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed89c36c499976f34fee0c36285ea76
https://www.mdpi.com/2075-4426/12/6/863/pdf?version=1655802182
https://www.mdpi.com/2075-4426/12/6/863/pdf?version=1655802182
Autor:
Sandra Flores‐Moreno, Nerea Báez-Gutiérrez, Laila Abdel-kader Martín, Héctor Rodríguez-Ramallo
Publikováno v:
British Journal of Clinical Pharmacology. 87:2635-2644
Aims To assess the appropriateness of the use and interpretation of subgroup analysis in haematology randomized clinical trials (RCTs). Method A systematic review of Medline, including haematology phase III RCTs published between January 2013 and Oct
Autor:
R. Otero Candelera, Héctor Rodríguez-Ramallo, L Abdel-kader Martín, S Flores-Moreno, Nerea Báez-Gutiérrez
Background. Pulmonary hypertension (PH) treatment decisions are driven by randomized controlled trials (RCTs) results. Subgroup analyses are often performed to assess whether the intervention effect will change due to the patient’s characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f88263eddc962472e2623e5de628671a
https://doi.org/10.21203/rs.3.rs-879986/v1
https://doi.org/10.21203/rs.3.rs-879986/v1
Autor:
Eduardo-Rodriguez Arboli, Héctor Rodríguez-Ramallo, María Antonia-Pérez Moreno, Nerea Báez-Gutiérrez, Laila Abdel-kader Martín
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Therapeutic Advances in Hematology
Digital.CSIC. Repositorio Institucional del CSIC
instname
Therapeutic Advances in Hematology
Digital.CSIC. Repositorio Institucional del CSIC
instname
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been the combination of the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax with hypomethylating agents (decitabine or azacytidine). This combination tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b5bbf927a25839700fef02bf5465229
https://hdl.handle.net/10668/4453
https://hdl.handle.net/10668/4453
Autor:
Laila Abdel-Kader Martin, Héctor Rodríguez Ramallo, Nerea Báez Gutiérrez, Marcos Fernández González
Publikováno v:
JMIR mHealth and uHealth. 10:e35851
Background Hematological malignancies (HMs) are a heterogeneous group of cancers representing a significant cause of morbidity and mortality. The chronification of HMs and the increasing use of smartphones may lead patients to seek their current unme